Tenet Healthcare's Cost Discipline, Outpatient Growth Drive Strong Q2 Performance, RBC Says

MT Newswires Live07-27

Tenet Healthcare (THC) is demonstrating improved operational execution as cost discipline across its hospital and ambulatory segments, along with growth in its United Surgical Partners International platform, supported a strong Q2 performance and raised outlook, RBC Capital said in a Sunday note.

According to the note, Tenet's adjusted earnings before interest, taxes, depreciation and amortization of $1.3 billion beat expectations, with revenue up 6.8% year over year to $5.6 billion, as margin expansion reflected cost management despite payer mix pressures, including lower exchange-related revenue.

The brokerage highlighted Tenet's raised 2026 adjusted EBITDA guidance of $4.83 billion to $5.03 billion, with the midpoint up $295 million from prior guidance, reflecting core business outperformance and cost structure flexibility amid changing payer dynamics.

The company's USPI platform is positioned to benefit from rising outpatient procedures, CMS inpatient-only list reforms and continued migration of procedures to ambulatory settings, supported by its acquisition pipeline, the report added.

RBC maintained its outperform rating on the stock and raised its price target to $283 from $236.

Tenet Healthcare shares were up over 5% in Monday trading.

Price: 246.67, Change: +13.47, Percent Change: +5.78

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2654580041?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-27 23:53","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2654580041","market":"us","top_or_hot":-1,"title":"Tenet Healthcare's Cost Discipline, Outpatient Growth Drive Strong Q2 Performance, RBC Says","media":"MT Newswires Live","content":"<html><body><p> Tenet Healthcare (THC) is demonstrating improved operational execution as cost discipline across its hospital and ambulatory segments, along with growth in its United Surgical Partners International platform, supported a strong Q2 performance and raised outlook, RBC Capital said in a Sunday note.</p><p>According to the note, Tenet's adjusted earnings before interest, taxes, depreciation and amortization of $1.3 billion beat expectations, with revenue up 6.8% year over year to $5.6 billion, as margin expansion reflected cost management despite payer mix pressures, including lower exchange-related revenue.</p><p>The brokerage highlighted Tenet's raised 2026 adjusted EBITDA guidance of $4.83 billion to $5.03 billion, with the midpoint up $295 million from prior guidance, reflecting core business outperformance and cost structure flexibility amid changing payer dynamics.</p><p>The company's USPI platform is positioned to benefit from rising outpatient procedures, CMS inpatient-only list reforms and continued migration of procedures to ambulatory settings, supported by its acquisition pipeline, the report added.</p><p>RBC maintained its outperform rating on the stock and raised its price target to $283 from $236.</p><p>Tenet Healthcare shares were up over 5% in Monday trading.</p><p>Price: 246.67, Change: +13.47, Percent Change: +5.78</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tenet Healthcare's Cost Discipline, Outpatient Growth Drive Strong Q2 Performance, RBC Says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTenet Healthcare's Cost Discipline, Outpatient Growth Drive Strong Q2 Performance, RBC Says\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-07-27 23:53</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Tenet Healthcare (THC) is demonstrating improved operational execution as cost discipline across its hospital and ambulatory segments, along with growth in its United Surgical Partners International platform, supported a strong Q2 performance and raised outlook, RBC Capital said in a Sunday note.</p><p>According to the note, Tenet's adjusted earnings before interest, taxes, depreciation and amortization of $1.3 billion beat expectations, with revenue up 6.8% year over year to $5.6 billion, as margin expansion reflected cost management despite payer mix pressures, including lower exchange-related revenue.</p><p>The brokerage highlighted Tenet's raised 2026 adjusted EBITDA guidance of $4.83 billion to $5.03 billion, with the midpoint up $295 million from prior guidance, reflecting core business outperformance and cost structure flexibility amid changing payer dynamics.</p><p>The company's USPI platform is positioned to benefit from rising outpatient procedures, CMS inpatient-only list reforms and continued migration of procedures to ambulatory settings, supported by its acquisition pipeline, the report added.</p><p>RBC maintained its outperform rating on the stock and raised its price target to $283 from $236.</p><p>Tenet Healthcare shares were up over 5% in Monday trading.</p><p>Price: 246.67, Change: +13.47, Percent Change: +5.78</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1201861165.SGD","symbol_name":"Natixis Harris Associates Global Equity PA SGD","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2654580041","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2654580041","pubTimestamp":1785167599,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Tenet Healthcare  is demonstrating improved operational execution as cost discipline across its hospital and ambulatory segments, along with growth in its United Surgical Partners International platform, supported a strong Q2 performance and raised outlook, RBC Capital said in a Sunday note.According to the note, Tenet's adjusted earnings before interest, taxes, depreciation and amortization of $1.3 billion beat expectations, with revenue up 6.8% year over year to $5.6 billion, as margin expansion reflected cost management despite payer mix pressures, including lower exchange-related revenue.The brokerage highlighted Tenet's raised 2026 adjusted EBITDA guidance of $4.83 billion to $5.03 billion, with the midpoint up $295 million from prior guidance, reflecting core business outperformance and cost structure flexibility amid changing payer dynamics.The company's USPI platform is positioned to benefit from rising outpatient procedures, CMS inpatient-only list reforms and continued migrat","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU1201861165.SGD":"Natixis Harris Associates Global Equity PA SGD","THC":"泰尼特","BK4588":"碎股","BK4585":"ETF&股票定投概念","BK4185":"保健护理机构","LU0648000940.SGD":"Natixis Harris Associates Global Equity RA SGD","THC.AU":"Hydroponics Company","XBI":"SPDR S&P Biotech ETF","BK4581":"高盛持仓","LABU":"三倍做多标普生物-Direxion","LU0130103400.USD":"Natixis Harris Associates Global Equity RA USD","LU0963586101.USD":"ALLIANZ GLOBAL SMALL CAP EQUITY \"AT\" ACC","LU2324357040.USD":"HSBC GIF GLOBAL EQUITY SUSTAINABLE HEALTHCARE \"AC\" (USD) ACC","XLV":"健康照护类股ETF-SPDR"},"translate_title":"加拿大皇家银行表示，Tenet Healthcare 的成本纪律和门诊增长推动了第二季度的强劲业绩","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"XLV":1.5,"THC.AU":1,"XBI":0.6,"THC":1.5,"LABU":0.6},"content_text":"Tenet Healthcare (THC) is demonstrating improved operational execution as cost discipline across its hospital and ambulatory segments, along with growth in its United Surgical Partners International platform, supported a strong Q2 performance and raised outlook, RBC Capital said in a Sunday note.According to the note, Tenet's adjusted earnings before interest, taxes, depreciation and amortization of $1.3 billion beat expectations, with revenue up 6.8% year over year to $5.6 billion, as margin expansion reflected cost management despite payer mix pressures, including lower exchange-related revenue.The brokerage highlighted Tenet's raised 2026 adjusted EBITDA guidance of $4.83 billion to $5.03 billion, with the midpoint up $295 million from prior guidance, reflecting core business outperformance and cost structure flexibility amid changing payer dynamics.The company's USPI platform is positioned to benefit from rising outpatient procedures, CMS inpatient-only list reforms and continued migration of procedures to ambulatory settings, supported by its acquisition pipeline, the report added.RBC maintained its outperform rating on the stock and raised its price target to $283 from $236.Tenet Healthcare shares were up over 5% in Monday trading.Price: 246.67, Change: +13.47, Percent Change: +5.78","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2654580041","isCrawlerRequest":true}